$115.41
1.46%
NYSE, Fri, Sep 06 2024
ISIN
US7140461093
Symbol
PKI

PerkinElmer Stock price

$115.41
-4.62 3.85% 1M
+8.10 7.55% 6M
+6.10 5.58% YTD
+3.98 3.57% 1Y
-75.09 39.42% 3Y
+31.67 37.82% 5Y
+69.97 153.98% 10Y
NYSE, Closing price Fri, Sep 06 2024
-1.71 1.46%
ISIN
US7140461093
Symbol
PKI
Sector

Key metrics

Market capitalization $14.23b
Enterprise Value $16.28b
P/E (TTM) P/E ratio 65.05
EV/FCF (TTM) EV/FCF 42.50
EV/Sales (TTM) EV/Sales 6.01
P/S ratio (TTM) P/S ratio 5.26
P/B ratio (TTM) P/B ratio 1.81
Dividend yield 0.24%
Last dividend (FY24) $0.28
Revenue growth (TTM) Revenue growth -4.54%
Revenue (TTM) Revenue $2.71b
EBIT (operating result TTM) EBIT $368.23m
Free Cash Flow (TTM) Free Cash Flow $382.96m
Cash position $1.95b
EPS (TTM) EPS $1.77
P/E forward 59.12
P/S forward 5.13
EV/Sales forward 5.86
Short interest 3.57%
Show more

Is PerkinElmer a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

PerkinElmer Stock Analysis

Unlock Scores for Free

Analyst Opinions

20 Analysts have issued a PerkinElmer forecast:

11x Buy
55%
9x Hold
45%

Analyst Opinions

20 Analysts have issued a PerkinElmer forecast:

Buy
55%
Hold
45%

Financial data from PerkinElmer

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
2,708 2,708
5% 5%
100%
- Direct Costs 1,301 1,301
4% 4%
48%
1,407 1,407
5% 5%
52%
- Selling and Administrative Expenses 409 409
9% 9%
15%
- Research and Development Expense 201 201
9% 9%
7%
797 797
10% 10%
29%
- Depreciation and Amortization 429 429
6% 6%
16%
EBIT (Operating Income) EBIT 368 368
23% 23%
14%
Net Profit 219 219
73% 73%
8%

In millions USD.

Don't miss a Thing! We will send you all news about PerkinElmer directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

PerkinElmer Stock News

Neutral
Business Wire
9 months ago
SHELTON, Conn.--(BUSINESS WIRE)--PerkinElmer, a leading global analytical services and solutions provider, today announced that it has acquired Covaris, a leading developer of solutions to empower life science innovations. The merger will accelerate Covaris' growth potential and expand PerkinElmer's existing life sciences portfolio into the high-growth diagnostics end market. Both companies are...
Neutral
GuruFocus
more than one year ago
On Tuesday, May 16, the name PerkinElmer and its PKI symbol disappeared from the stock market. In its place is a piece of the old company, branded as Revvity Inc. ( RVTY , Financial).
Neutral
Seeking Alpha
more than one year ago
PerkinElmer, Inc. (NYSE:PKI ) Q4 2022 Earnings Conference Call February 14, 2023 8:00 AM ET Company Participants Steve Willoughby - SVP, IR Prahlad Singh - President and CEO Max Krakowiak - SVP and CFO Conference Call Participants Derik de Bruin - Bank of America Patrick Donnelly - Citi Joshua Waldman - Cleveland Research Liza Garcia - UBS Dan Arias - Stifel Jack Meehan - Nephron Research Paul ...
More PerkinElmer News

Company Profile

PerkinElmer, Inc. engages in the provision of products, services, and solutions for diagnostics, food, environmental, life sciences, and applied markets. It operates through the following segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment comprises of technologies that help life sciences researchers better understand diseases and develop treatments. The Diagnostics segment offers instruments, reagents, assay platforms, and software to hospitals, medical labs, clinicians, and medical research professionals to help improve the health of families. The company was founded by Richard Scott Perkin and Charles W. Elmer on April 19, 1937 and is headquartered in Waltham, MA.

Head office United States
CEO Prahlad Singh
Employees 11,500
Founded 1937
Website www.revvity.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today